Quarterly report pursuant to Section 13 or 15(d)

CONSOLIDATED STATEMENTS OF CASH FLOWS

v3.4.0.3
CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($)
$ in Thousands
 3 Months Ended
Mar. 31, 2016
Mar. 31, 2015
Cash flows from operating activities:    
Net income (loss) $ 982 $ (18,725)
Adjustments to reconcile net income (loss) to net cash provided by operating activities:    
Depreciation and amortization expense 47,142 45,235
Unrealized (income) loss on derivative instrument with related party (4,530) 2,120
Deferred income tax expense (benefit) 3,067 (6,786)
Share-based compensation expense 2,327 2,801
Software impairment charge 0 26,417
Other noncash income and expense items 2,446 4,818
Change in operating assets and liabilities (9,509) 18,837
Net cash provided by operating activities 41,925 74,717
Cash flows from investing activities:    
Purchases of property and equipment (44,598) (49,332)
Purchases of other assets and intangible assets (3,947) (2,808)
Note receivable payment from an equity method investee 3,000 0
Grant proceeds 0 14,007
Note receivable issued to an equity method investee 0 (3,000)
Purchase of business, net of cash received 0 (2,167)
Other (8) (4,877)
Net cash used for investing activities (45,553) (48,177)
Cash flows from financing activities:    
Borrowing on Amended Senior Credit Facility 25,000 295,000
Repayment of debt and capital lease obligations (22,955) (61,350)
Purchase of treasury stock to be retired (11,551) (16,993)
Purchase of noncontrolling interests 0 (280,505)
Issuance of Searchlight note payable and derivative stock appreciation rights with related party 0 75,000
Payment of debt issuance costs 0 (5,853)
Distribution to non-controlling interest 0 (4,932)
Other 64 498
Net cash (used for) provided by financing activities (9,442) 865
Net increase (decrease) in cash and cash equivalents (13,070) 27,405
Cash and cash equivalents at beginning of period 26,528 15,402
Cash and cash equivalents at end of period $ 13,458 $ 42,807